Zoekresultaten - 38 results
Surveillance of Bloodstream Infections in Belgian Hospitals- Annual report 2023, Data up to and including 2022
being the most commonly isolated from hospital-wide CLABSI cases. Long-term increasing trends can be observed for hospital-wide HABSI incidences due to E. coli, K. pneumoniae, and E. faecium. The trend of ...
Surveillance of Bloodstream Infections in Belgian Hospitals- Annual report 2023, Data up to and including 2022
this last MO also being the most commonly isolated from hospital-wide CLABSI cases. Long-term increasing trends can be observed for hospital-wide HABSI incidences due to E. coli, K. pneumoniae, and E. ...
Epidemiology of COVID-19 mortality in Belgium from wave 1 to wave 7 (March 2020 – 11 September 2022)
residents (65+). COVID-19 case fatality ratio The COVID-19 case-fatality ratio (CFR) in Belgium was estimated to be 0.65%, but it increased exponentially with age (4.92% for 75-84 years old and 9.87% above 85 years ...
Prevalence of anti-SARS-CoV-2 antibodies in the general population in Belgium: Results of the second data collection (28/09/21-23/02/22)
2 (27/09-24/10) the percentage of adults (18 years or older) with anti- SARS-CoV-2 antibodies has increased from 69.5% to 90.4%. This substantial increase is in line with the intensive vaccination campaign during ...
Citizens’ perception of and engagement with health data secondary use and sharing in Europe – a literature review
different nature arise when health data is being processed. The role of citizens in the processing of health data seems to be increasingly acknowledged at the European political level. Nonetheless, the only ...
Surveillance of COVID-19 mortality in Belgium, epidemiology and methodology during 1st and 2nd wave (March 2020- 14 February 2021)
hospitals (61%) than in nursing homes for elderly (NH s) (38%). In contrast, during the first wave, this distribution was more equal (50% in hospitals and 49% in NH s). The test capacity increased and the ...
Morbidity Statistics: 2019 Pilot Data Collection Belgium, Final Report
were initiated while paving the way for enhanced future data exchanges and collaborations within other projects. Methodologies and tools were developed to increase the reproducibility of the analyses and ...
Annual Report Belgian Cystic Fibrosis Registry 2018
Pseudomonas aeruginosa reported in 2018 was 37.9%. This is in line with the general decline observed from 42.4% in 2012 to 37.5% in 2016. There has also been a steady increase in the prevalence of Achromobacter ...
Annual Report Belgian Cystic Fibrosis Registry 2017
increased since the decline observed from 42.4% in 2012 to 37.5% in 2016. There has also been a steady increase in the prevalence of Achromobacter xylosoxidans from 5.9% in 2009, stabilizing at prevalence ...
Surveillance of antimicrobial resistant bacteria in Belgian hospitals: Report 2016
Enterobacteriaceae, especially in Klebsiella pneumoniae (K. pneumoniae) in acute care hospitals. The mean resistance proportion of extended beta-lactamase producing (ESBL +) K. pneumoniae increased from 6.2% in 2005 to ...